Lepidext
Lexington, US · Founded 2015 · Delaware corporation · 3 known investors
Lepidext develops a biocontrol product based on a naturally-occurring corn earworm virus isolate that increases sterility in infected insects, aimed at controlling corn earworm in agricultural crops. The company holds a patent on the isolate and has submitted an EPA registration application ahead of commercialization.
AgTechBiotech
Founders & leadership
PM
Paul MulhollemNamed on SEC filing
AF
Angelika Fath-GoodinCo-founder
GP
Gary P CullenNamed on SEC filing
BW
Bruce WebbFounder & President
Investors · 3
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 2 rounds · 2020–2022
▶$700KraisedMay 2022 · 5 investors · AgricultureRule 506(b)
▶$700KraisedMay 2022 · 5 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Bruce WebbExecutive Officer, Director
- Angelika Fath-GoodinExecutive Officer, Director
- Paul MulhollemDirector
- Gary CullenDirector
- Offering amount
- $1.5M
- Amount sold
- $700K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$535.4KraisedMay 2020 · 9 investors · AgricultureRule 506(b)
▶$535.4KraisedMay 2020 · 9 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Paul MulhollemDirector
- Angelika Fath-GoodinExecutive Officer, Director
- Gary P CullenDirector
- Bruce WebbExecutive Officer, Director
- Offering amount
- $575K
- Amount sold
- $535.4K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase ISTTR | 2023 | $175K |
| National Science Foundation | Phase I | 2022 | $256K |
| Department of Agriculture (USDA) | Phase I | 2021 | $106.5K |
| Department of Agriculture (USDA) | Phase I | 2018 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Lepidext do?
- Lepidext develops a biocontrol product based on a naturally-occurring corn earworm virus isolate that increases sterility in infected insects, aimed at controlling corn earworm in agricultural crops. The company holds a patent on the isolate and has submitted an EPA registration application ahead of commercialization.
- Who are Lepidext's investors?
- Lepidext's investors include Ag Ventures Alliance, Bluegrass Angel Venture, Cultivation Capital.
- How much funding has Lepidext raised?
- Lepidext has disclosed $1.2M raised across 2 rounds.
- Where is Lepidext headquartered?
- Lepidext is headquartered in Lexington, US.